Advances with the use of bio-inspired vectors towards creation of artificial viruses
- PMID: 20151849
- DOI: 10.1517/17425240903579989
Advances with the use of bio-inspired vectors towards creation of artificial viruses
Abstract
Importance of the field: In recent years, there has been a great deal of interest in the development of recombinant vectors based on biological motifs with potential applications in gene therapy. Several such vectors have been genetically engineered, resulting in biomacromolecules with new properties that are not present in nature.
Areas covered in this review: This review briefly discusses the advantages and disadvantages of the current state-of-the-art gene delivery systems (viral and non-viral) and then provides an overview on the application of various biological motifs in vector development for gene delivery. Finally, it highlights some of the most advanced bio-inspired vectors that are designed to perform several self-guided functions.
What the reader will gain: This review helps the readers get a better understanding about the history and evolution of bio-inspired fusion vectors with the potential to merge the strengths of both viral and non-viral vectors in order to create efficient, safe and cost-effective gene delivery systems.
Take home message: With the emergence of new technologies such as recombinant bio-inspired vectors, it may not take long before non-viral vectors are observed that are not just safe and tissue-specific, but even more efficient than viral vectors.
Similar articles
-
Viral vector-mediated gene transfer for CNS disease.Expert Opin Biol Ther. 2010 Mar;10(3):381-94. doi: 10.1517/14712590903514074. Expert Opin Biol Ther. 2010. PMID: 20132059 Review.
-
Ultrasound-mediated gene delivery.Expert Opin Drug Deliv. 2010 Mar;7(3):321-30. doi: 10.1517/17425241003596329. Expert Opin Drug Deliv. 2010. PMID: 20166854 Review.
-
Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.Biotechnol Prog. 2008 Jul-Aug;24(4):871-83. doi: 10.1021/bp070319o. Biotechnol Prog. 2008. PMID: 18335953 Review.
-
Vectors--shuttle vehicles for gene therapy.Clin Exp Immunol. 1997 Jan;107 Suppl 1:31-2. Clin Exp Immunol. 1997. PMID: 9020933 Review.
-
Gene therapy for haemophilia...yes, but...with non-viral vectors?Haemophilia. 2009 May;15(3):811-6. doi: 10.1111/j.1365-2516.2009.02010.x. Haemophilia. 2009. PMID: 19432929
Cited by
-
Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.Biomacromolecules. 2017 Sep 11;18(9):2799-2807. doi: 10.1021/acs.biomac.7b00739. Epub 2017 Aug 24. Biomacromolecules. 2017. PMID: 28806522 Free PMC article.
-
Bluetongue Virus Particles as Nanoreactors for Enzyme Delivery and Cancer Therapy.Mol Pharm. 2021 Mar 1;18(3):1150-1156. doi: 10.1021/acs.molpharmaceut.0c01053. Epub 2021 Feb 10. Mol Pharm. 2021. PMID: 33566625 Free PMC article.
-
HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.Nanomedicine. 2011 Apr;7(2):193-200. doi: 10.1016/j.nano.2010.08.003. Epub 2010 Oct 1. Nanomedicine. 2011. PMID: 20817124 Free PMC article.
-
Treatment of Rheumatoid Arthritis with Gene Therapy Applications: Biosafety and Bioethical Considerations.BioTech (Basel). 2021 Jun 23;10(3):11. doi: 10.3390/biotech10030011. BioTech (Basel). 2021. PMID: 35822765 Free PMC article.
-
DNA vaccination for prostate cancer: key concepts and considerations.Cancer Nanotechnol. 2015;6(1):2. doi: 10.1186/s12645-015-0010-5. Epub 2015 Jul 2. Cancer Nanotechnol. 2015. PMID: 26161151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials